Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-13

Clinical Trial Update: Perioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

The entry notes the completion of a Phase 4 trial evaluating perioperative fosfomycin for prevention of urinary tract infection in kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosfomycin (Fosfomycin)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Urinary Tract Infection, Asymptomatic Bacteriuria | Phase 4 | Status: COMPLETED